Taking Evolution to the Clinic
Elie Dolgin • November 3, 2015
An exploration of what might be possible when basic researchers and physicians collaborate as part of an area sometimes called “evolutionary medicine.”
Continue reading here.
Paul Mischel is championing the importance of odd rings of DNA in tumors — and their promise as targets for cancer therapy.
Edits create cells that don’t trigger an immune response, allowing implant recipient to forego immune-suppressing drugs.